Aquestive Therapeutics to Participate in Two Upcoming Conferences in March

Core Insights - Aquestive Therapeutics, Inc. is participating in two investor conferences in March 2025, including the Leerink's Global Biopharma Conference and Barclays 27th Annual Global Healthcare Conference [1][4] Company Overview - Aquestive is a pharmaceutical company focused on advancing medicines through innovative science and delivery technologies, developing orally administered and topical gel products to deliver complex molecules [2] - The company has five commercialized products marketed in the U.S. and globally, and it is the exclusive manufacturer of these licensed products [2] - Aquestive is advancing a late-stage proprietary product candidate for treating severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug topical gel for various dermatology conditions, including alopecia areata [2] Upcoming Events - The Leerink's Global Biopharma Conference will take place from March 10 to March 12, with a fireside chat scheduled for March 10th at 4:20-4:50 PM EST, and management will be available for one-on-one meetings [4] - The Barclays 27th Annual Global Healthcare Conference will occur from March 11 to March 13, with management also available for one-on-one meetings on March 12 [4]